Sort   by:  
 Page size 
UnknownInverse FASN and LDHA correlation drives metabolic resistance in breast cancer.
Not available
S-EPMC11267768 | biostudies-literature
UnknownITGB1 and DDR activation as novel mediators in acquired resistance to osimertinib and MEK inhibitors in EGFR-mutant NSCLC.
Not available
S-EPMC10766645 | biostudies-literature
UnknownInteraction between MyD88, TIRAP and IL1RL1 against Helicobacter pylori infection.
Not available
S-EPMC7522988 | biostudies-literature
UnknownGut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab.
Not available
S-EPMC9321613 | biostudies-literature
UnknownCombined Therapeutic Strategies Based on the Inhibition of Non-Oncogene Addiction to Improve Tumor Response in EGFR- and KRAS-Mutant Non-Small-Cell Lung Cancer.
Not available
S-EPMC11639923 | biostudies-literature
UnknownImmune-Cell-Derived Exosomes as a Potential Novel Tool to Investigate Immune Responsiveness in SCLC Patients: A Proof-of-Concept Study.
Not available
S-EPMC11430591 | biostudies-literature
UnknownAnti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: findings from the CAVE-Lung trial.
Not available
S-EPMC8962159 | biostudies-literature
UnknownPBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer.
Not available
S-EPMC11048624 | biostudies-literature
UnknownNovel applications of liquid Biopsy: Comprehensive methodology for circulating biomarker exploration in peripheral blood.
Not available
S-EPMC12272590 | biostudies-literature
UnknownDNA-PK inhibition sustains the antitumor innate immune response in small cell lung cancer.
Not available
S-EPMC11875153 | biostudies-literature
Sort   by:  
 Page size